MediLink and Roche Strengthen Collaboration with New Exclusive Licensing Agreement MediLink Therapeutics has entered a new exclusive agreement with Roche to develop YL201, a promising ADC for various solid tumors. This partnership aims to expedite global patient access.

MediLink and Roche Strengthen Collaboration with New Exclusive Licensing Agreement #China #Suzhou #Roche #MediLink #YL201